Search Result "imatinib-resistance"


Gastrointestinal Stromal Tumors: A Paradigm for Therapeutic Options in Solid Organ Tumors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 10 Issue: 7 Year: 2010 Page: 624-634
Author(s): Caroline Novak, Jose G. Trevino

in vitro Anti-leukaemia Activity of Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs)

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5 Issue: 1 Year: 2010 Page: 58-68
Author(s): Gabriella Marfe, Carla Di Stefano

Personalized Medicine in Oncology: A Personal View with Myths and Facts

Journal: Current Clinical Pharmacology
Volume: 5 Issue: 3 Year: 2010 Page: 141-147
Author(s): Jos H. Beijnen, Jan H.M. Schellens

Journal: Current Drug Targets
Volume: 11 Issue: 7 Year: 2010 Page: 834-850
Author(s): Marcus W. Wiedmann, Joachim Mossner

Valproic Acid in the Complex Therapy of Malignant Tumors

Journal: Current Drug Targets
Volume: 11 Issue: 3 Year: 2010 Page: 361-379
Author(s): J. Hrebackova, J. Hrabeta, T. Eckschlager

Herbal Interactions with Anticancer Drugs: Mechanistic and Clinical Considerations

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 1 Year: 2010 Page: 1635-1678
Author(s): An-Kui Yang, Shu-Ming He, Liang Liu, Jun-Ping Liu, Ming Qian Wei, Shu-Feng Zhou

Targeting Drug Resistant Mutations Using Novel Binding Interactions - Lessons Learned from Abl-T315I and their Implications in D

Ebook: Young People’s Visions of the World

Volume: 3 Year: 2010
Author(s): Glen Noronha,Jianguo Cao,Chun Chow,Elena Dneprovskaia,Linda Hwang,Dan Lohse,Chi Ching Mak,Andrew McPherson,Richard M. Fine,Xinshan Kang,Boris Klebansky,Moorthy S.S. Palanki,Ved P. Pathak,Joel Renick,Richard Soll,Binqi Zeng
Doi: 10.2174/97816080520111070301

New Opportunities to Treat the T315I-Bcr-Abl Mutant in Chronic Myeloid Leukaemia: Tyrosine Kinase Inhibitors and Molecules that Act by Alternative Mechanisms

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 1 Year: 2010 Page: 1220-1245
Author(s): S. Schenone, C. Brullo, M. Botta

P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase Inhibitor

Journal: Drug Metabolism Letters
Volume: 4 Issue: 4 Year: 2010 Page: 202-212
Author(s): Johnny J. Yang, Mark N. Milton, Shaoxia Yu, Mingxiang Liao, Ning Liu, Jing-Tao Wu, Liang-Shang Gan, Suresh K. Balani, Frank W. Lee, Shimoga Prakash, Cindy Q. Xia

siRNA-Mediated Knock-Down of P-Glycoprotein Expression Reveals Distinct Cellular Disposition of Anticancer Tyrosine Kinases Inhibitors

Journal: Drug Metabolism Letters
Volume: 4 Issue: 2 Year: 2010 Page: 114-119
Author(s): Amina Haouala, Holger Rumpold, Gerold Untergasser, Thierry Buclin, Hans-Beat Ris, Nicolas Widmer, Laurent A. Decosterd

Previous   Next

Go To   Results 1 - 1 of 127

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy